Baird Downgrades Biogen (BIIB) to Neutral Following Quick 35% Jump Following BAN2401
Tweet Send to a Friend
Baird downgraded Biogen (NASDAQ: BIIB) from Outperform to Neutral with a price target of $323.00.Analyst Brian P. Skorney commented, "Following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
